Notice Title

Consent to the Distribution of a New Medicine

Publication Date
4 Sep 2025

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2025-go4897
Title
View PDF
File Type and Size
PDF (21 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Keytruda
Active Ingredient: Pembrolizumab 25mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: MSD International GmbH (Singapore Branch), Singapore City, Singapore
MSD International GmbH t/a MSD Ireland (Carlow), Carlow, Ireland


Dated this 1st day of September 2025.

MATTHEW SPENCER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).